Literature DB >> 12719572

Infection-triggered regulatory mechanisms override the role of STAT 4 in control of the immune response to influenza virus antigens.

A Bot1, E Rodrigo, T Wolfe, S Bot, M G Von Herrath.   

Abstract

Accurate control of the balance of the T1 and T2 cells during antiviral immunity is essential for optimizing immune effector functions and for avoiding potentially severe immunopathology. We examined the in vivo role of the signal transducer and activator of transcription (STAT) 4 in regulating the T1/T2 balance during the response to live influenza virus and isolated viral proteins. We found that the differentiation of gamma interferon (IFN-gamma)-producing Th1 and Tc1 cells after inoculation of live virus occurred independently of STAT 4 expression. Influenza virus-specific T2 and Tc2 responses were well controlled in such STAT 4-deficient mice unless IFN-gamma was eliminated as well. In contrast, the STAT 4-dependent signaling pathway played a more essential role in regulating the T1/T2 balance after immunization with viral proteins and, in particular, inactivated nonreplicating virus. Pulmonary infection was cleared even in the absence of both functional STAT 4 genes and functional IFN-gamma genes because virus-neutralizing antibodies were still generated, consistent with a substantial redundancy in different antiviral effector pathways. Thus, replicating agents such as live influenza virus can elicit IFN-gamma and control T2 immunity independently of STAT 4, whereas the profile of immunity to isolated proteins is more reliant on an intact STAT 4 signaling pathway.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12719572      PMCID: PMC154013          DOI: 10.1128/jvi.77.10.5794-5800.2003

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  35 in total

1.  T-bet is rapidly induced by interferon-gamma in lymphoid and myeloid cells.

Authors:  A A Lighvani; D M Frucht; D Jankovic; H Yamane; J Aliberti; B D Hissong; B V Nguyen; M Gadina; A Sher; W E Paul; J J O'Shea
Journal:  Proc Natl Acad Sci U S A       Date:  2001-12-18       Impact factor: 11.205

Review 2.  Modes of action of Freund's adjuvants in experimental models of autoimmune diseases.

Authors:  A Billiau; P Matthys
Journal:  J Leukoc Biol       Date:  2001-12       Impact factor: 4.962

3.  Distinct effects of T-bet in TH1 lineage commitment and IFN-gamma production in CD4 and CD8 T cells.

Authors:  Susanne J Szabo; Brandon M Sullivan; Claudia Stemmann; Abhay R Satoskar; Barry P Sleckman; Laurie H Glimcher
Journal:  Science       Date:  2002-01-11       Impact factor: 47.728

Review 4.  Influenza.

Authors:  N J Cox; K Subbarao
Journal:  Lancet       Date:  1999-10-09       Impact factor: 79.321

5.  Inhibition of tumor necrosis factor reduces the severity of virus-specific lung immunopathology.

Authors:  T Hussell; A Pennycook; P J Openshaw
Journal:  Eur J Immunol       Date:  2001-09       Impact factor: 5.532

Review 6.  Further checkpoints in Th1 development.

Authors:  Douglas S Robinson; Anne O'Garra
Journal:  Immunity       Date:  2002-06       Impact factor: 31.745

7.  Multiple defects of immune cell function in mice with disrupted interferon-gamma genes.

Authors:  D K Dalton; S Pitts-Meek; S Keshav; I S Figari; A Bradley; T A Stewart
Journal:  Science       Date:  1993-03-19       Impact factor: 47.728

8.  Hlx is induced by and genetically interacts with T-bet to promote heritable T(H)1 gene induction.

Authors:  Alan C Mullen; Anne S Hutchins; Frances A High; Hubert W Lee; Kara J Sykes; Lewis A Chodosh; Steven L Reiner
Journal:  Nat Immunol       Date:  2002-06-10       Impact factor: 25.606

9.  Interleukin 12 signaling in T helper type 1 (Th1) cells involves tyrosine phosphorylation of signal transducer and activator of transcription (Stat)3 and Stat4.

Authors:  N G Jacobson; S J Szabo; R M Weber-Nordt; Z Zhong; R D Schreiber; J E Darnell; K M Murphy
Journal:  J Exp Med       Date:  1995-05-01       Impact factor: 14.307

10.  Response to influenza infection in mice with a targeted disruption in the interferon gamma gene.

Authors:  M B Graham; D K Dalton; D Giltinan; V L Braciale; T A Stewart; T J Braciale
Journal:  J Exp Med       Date:  1993-11-01       Impact factor: 14.307

View more
  11 in total

1.  STAT4 genetic polymorphisms association with spontaneous clearance of hepatitis B virus infection.

Authors:  Yanjun Lu; Yaowu Zhu; Jing Peng; Xiong Wang; Feng Wang; Ziyong Sun
Journal:  Immunol Res       Date:  2015-06       Impact factor: 2.829

Review 2.  STAT4: a critical regulator of inflammation in vivo.

Authors:  Mark H Kaplan
Journal:  Immunol Res       Date:  2005       Impact factor: 2.829

3.  STAT4 deficiency fails to induce lung Th2 or Th17 immunity following primary or secondary respiratory syncytial virus (RSV) challenge but enhances the lung RSV-specific CD8+ T cell immune response to secondary challenge.

Authors:  Daniel E Dulek; Dawn C Newcomb; Shinji Toki; Kasia Goliniewska; Jacqueline Cephus; Sara Reiss; John T Bates; James E Crowe; Kelli L Boyd; Martin L Moore; Weisong Zhou; R Stokes Peebles
Journal:  J Virol       Date:  2014-06-11       Impact factor: 5.103

4.  Bioinformatics analyses of significant genes, related pathways, and candidate diagnostic biomarkers and molecular targets in SARS-CoV-2/COVID-19.

Authors:  Basavaraj Vastrad; Chanabasayya Vastrad; Anandkumar Tengli
Journal:  Gene Rep       Date:  2020-11-04

5.  STAT4 regulates antiviral gamma interferon responses and recurrent disease during herpes simplex virus 2 infection.

Authors:  Alexandra Svensson; Petra Tunbäck; Inger Nordström; Andrey Shestakov; Leonid Padyukov; Kristina Eriksson
Journal:  J Virol       Date:  2012-06-20       Impact factor: 5.103

6.  STAT4 is a critical mediator of early innate immune responses against pulmonary Klebsiella infection.

Authors:  Jane C Deng; Xianying Zeng; Michael Newstead; Thomas A Moore; Wan C Tsai; Victor J Thannickal; Theodore J Standiford
Journal:  J Immunol       Date:  2004-09-15       Impact factor: 5.422

7.  Virus-specific CD4 and CD8 T cell responses in the absence of Th1-associated transcription factors.

Authors:  Sarah B Mollo; Jennifer T Ingram; Robert L Kress; Allan J Zajac; Laurie E Harrington
Journal:  J Leukoc Biol       Date:  2013-11-14       Impact factor: 4.962

Review 8.  The Dynamic Interface of Viruses with STATs.

Authors:  Angela R Harrison; Gregory W Moseley
Journal:  J Virol       Date:  2020-10-27       Impact factor: 5.103

9.  Transcription factor regulation and cytokine expression following in vitro infection of primary chicken cell culture with low pathogenic avian influenza virus.

Authors:  Haijun Jiang; Kangzhen Yu; Darrell R Kapczynski
Journal:  Virol J       Date:  2013-11-19       Impact factor: 4.099

10.  Involvement of STAT4 in IgG subtype switching and ocular HSV-1 replication in mice.

Authors:  Sariah J Allen; Kevin R Mott; Homayon Ghiasi
Journal:  Mol Vis       Date:  2010-01-26       Impact factor: 2.367

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.